Heartland Advisors’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
PCMI
Heartland Advisors's ANGO Position: Q1 2024 in Review
Heartland Advisors sold out of AngioDynamics (ANGO) in Q1 2024, closing a stake of 287,192 shares — an estimated $2.43M sold.
Heartland Advisors first reported a position in ANGO in Q1 2018 and held it in 24 quarters. The position peaked at $11M in Q3 2018. 135 funds tracked by Wall St. Rank hold ANGO as of Q1 2024.
- Heartland Advisors reported no remaining AngioDynamics position as of Q1 2024 after selling out during the quarter.
- Heartland Advisors sold 287,192 AngioDynamics shares in Q1 2024, an estimated $2.43M.
- Heartland Advisors first reported a position in AngioDynamics in Q1 2018 and held it in 24 quarters.
- Heartland Advisors's AngioDynamics position peaked at $11M in Q3 2018.
- 135 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2024.
Based on Heartland Advisors's 13F filing for Q1 2024, filed 7 May 2024.